Literature DB >> 19667318

Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study.

B Segura1, M A Jurado, N Freixenet, C Falcón, C Junqué, A Arboix.   

Abstract

BACKGROUND: Although metabolic syndrome is associated with cardiovascular disease and stroke, limited information is available on specific brain damage in patients with this syndrome. We investigated the relationship of the syndrome with white matter (WM) alteration using a voxel-based approach with diffusion tensor imaging (DTI).
METHODS: We compared fractional anisotropy (FA) and apparent diffusion coefficient (ADC) measurements of DTI in 19 patients with metabolic syndrome aged between 50 and 80 years and 19 age-matched controls without any vascular risk factors for the syndrome.
RESULTS: Patients with metabolic syndrome showed an anterior-posterior pattern of deterioration in WM with reduced FA and increased ADC values compared with controls. WM changes were not related to any isolated vascular risk factor.
CONCLUSION: Although the mechanism of this damage is not clear, the results indicate microstructural white matter alterations in patients with metabolic syndrome, mainly involving the frontal lobe.

Entities:  

Mesh:

Year:  2009        PMID: 19667318     DOI: 10.1212/WNL.0b013e3181b163cd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

1.  Abnormal cholesterol is associated with prefrontal white matter abnormalities among obese adults, a diffusion tensor imaging study.

Authors:  Jessica I Cohen; Fanny Cazettes; Antonio Convit
Journal:  Neuroradiol J       Date:  2011-11-15

2.  4th Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12-14, 2011, Budapest, Hungary.

Authors:  Boris N Mankovsky
Journal:  Diabetes Technol Ther       Date:  2011-10-04       Impact factor: 6.118

3.  Metabolic syndrome and localization of white matter hyperintensities in the elderly population.

Authors:  Florence Portet; Adam M Brickman; Yaakov Stern; Nikolaos Scarmeas; Jordan Muraskin; Frank A Provenzano; Claudine Berr; Alain Bonafé; Sylvaine Artero; Karen Ritchie; Tasnime N Akbaraly
Journal:  Alzheimers Dement       Date:  2012-06-06       Impact factor: 21.566

Review 4.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

5.  Vascular Dementia.

Authors:  Alberto R Ramos; Salim I Dib; Clinton B Wright
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

6.  Insulin resistance is associated with poorer verbal fluency performance in women.

Authors:  Laura L Ekblad; Juha O Rinne; Pauli J Puukka; Hanna K Laine; Satu E Ahtiluoto; Raimo O Sulkava; Matti H Viitanen; Antti M Jula
Journal:  Diabetologia       Date:  2015-08-15       Impact factor: 10.122

7.  Functional MR imaging evidence of altered functional activation in metabolic syndrome.

Authors:  K F Hoth; M M Gonzales; T Tarumi; S C Miles; H Tanaka; A P Haley
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

Review 8.  Impact of metabolic syndrome on cognition and brain: a selected review of the literature.

Authors:  Kathy F Yates; Victoria Sweat; Po Lai Yau; Michael M Turchiano; Antonio Convit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

9.  Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.

Authors:  Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine
Journal:  J Neurovirol       Date:  2020-07-30       Impact factor: 2.643

10.  Metabolic syndrome, brain magnetic resonance imaging, and cognition.

Authors:  Margherita Cavalieri; Stefan Ropele; Katja Petrovic; Aga Pluta-Fuerst; Nina Homayoon; Christian Enzinger; Anja Grazer; Petra Katschnig; Petra Schwingenschuh; Andrea Berghold; Reinhold Schmidt
Journal:  Diabetes Care       Date:  2010-09-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.